NCT04873271 - Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

August 4, 2021

Study Completion Date

July 8, 2022

Conditions

Overactive Bladder

Interventions

DEVICE

Medtronic Implantable Tibial Neuromodulation (TNM) System

Tibial neuromodulation (TNM) devices are implantable devices that provide stimulation to the tibial nerve.

Trial Locations (7)

FirstHealth Urogynecology, Hamlet

Prisma Health, Greenville

Georgia Urology, Marietta

Milwaukee Urogynecology Ascension Medical Group, Milwaukee

Sanford Health, Sioux Falls

Urology Partners of North Texas, Arlington

Urologic Research and Consulting, Englewood